Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis.

MLA

Cui, Ran, et al. “Efficacy and Safety of Concurrent Immune Checkpoint Inhibitors Combined with Radiotherapy or Chemoradiotherapy for Advanced Non-Small Cell Lung Cancer: A Systematic Review and Single-Arm Meta-Analysis.” PLoS ONE, vol. 19, no. 6, June 2024, pp. 1–21. EBSCOhost, https://doi.org/10.1371/journal.pone.0304941.

APA

Cui, R., Li, Y., Yu, X., Wei, C., & Jiang, O. (2024). Efficacy and safety of concurrent immune checkpoint inhibitors combined with radiotherapy or chemoradiotherapy for advanced non-small cell lung cancer: A systematic review and single-arm meta-analysis. PLoS ONE, 19(6), 1–21. https://doi.org/10.1371/journal.pone.0304941

Chicago

Cui, Ran, Yun Li, Xinlin Yu, Chun Wei, and Ou Jiang. 2024. “Efficacy and Safety of Concurrent Immune Checkpoint Inhibitors Combined with Radiotherapy or Chemoradiotherapy for Advanced Non-Small Cell Lung Cancer: A Systematic Review and Single-Arm Meta-Analysis.” PLoS ONE 19 (6): 1–21. doi:10.1371/journal.pone.0304941.